Increased expression of interleukin-18 and its receptor in peripheral blood of patients with chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 4, 2012, Pages 375-381

  Wang, Jianmiao ^a   Liu, Xiansheng ^a   Xie, Min ^a   Xie, Jungang ^a   Xiong, Weining ^a   Xu, Yongjian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C reactive protein; Chronic obstructive pulmonary disease; Interleukin 18; Interleukin 18 receptor

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CHEMOLUMINESCENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; T LYMPHOCYTE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 84865187115     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.670330     Document Type: Article

References (29)

1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-504.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55.
3. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613-20.
4. Saetta M, Di Stefano A, Maestrelli P, et al. Activatedt lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.
5. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:711-17.
6. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic infl ammation: a systematic review and a meta-analysis. Th orax 2004; 59:574-80.
7. Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers and non-smokers. Th orax 2006; 61:23-8.
8. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003; 73:213-24.
9. McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Th er 2005; 7:38-41.
10. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004; 11:405-10.
11. Dinarello CA. IL-18: a Th 1-inducing, proinfl amatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:11-24.
12. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th 1 and Th 2 responses. Annu Rev Immunol 2001; 19:423-74.
13. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFNgamma production by T cells. Nature 1995; 378:88-91.
14. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th 1 and Th 2 responses. Annu Rev Immunol 2001; 19:423-74.
15. Dinarello CA. Interleukin-18, a proinfl ammatory cytokine. Eur Cytokine Netw 2000; 11:483-6.
16. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, Akira S. Cutting edge: generation of IL-18 receptor-defi cient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 1999; 162:5041-4.
17. Debets R, Timans JC, Churakowa T, Zurawski S, de Waal Malefyt R, Moore KW, et al. IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody,a potent antagonist of IL-18. J Immunol 2000; 165:4950-6.
18. Kang MJ, Homer RJ, Gallo A, Lee CG, Crothers KA, Cho SJ, et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and infl ammation. J Immunol 2007; 178:1948-59.
19. Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T, et al. Interleukin-18 production and pulmonary function in COPD. Eur Respir J 2008; 31:287-97.
20. Freeman CM, Han MK, Martinez FJ, Murray S, Liu LX, Chensue SW, et al. Cytotoxic potential of lung CD8+ T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol 2010; 184:6504-13.
21. GOLD. Global initiative for chronic obstructive lung disease (GOLD): report of the GOLD workshop, global strategy for diagnosis, management and prevention of COPD. Updated 2009. http://www.goldcopd.org Accessed: 15 March 2010.
22. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-68.
23. Wouters EF. Local and systemic infl ammation in chronic obstructive pulmonary disease. Proc Am Th orac Soc 2005; 2:26-33.
24. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of infl ammation: Data from the third national health and nutrition examination. Am J Med 2003; 114:758-62.
25. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fi brinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1008-11.
26. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154:1055-60.
27. Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic infl ammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010; 11:63.
28. Franciosi LG, Page CP, Celli BR, et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Th erap 2006; 19:189-99.
29. de Jong JW, van der Belt-Gritter B, Koeter GH, Postma DS. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 1997; 91:67-76.